The mRNA's industry is presently experiencing remarkable growth, fueled by the triumphant deployment of mRNA-based medications against COVID-19. Studies reveal a intricate landscape, with ongoing funding into therapeutic applications beyond infectious diseases, including areas such as oncology, rare diseases, and protein replacement therapy. Region